Calidi Biotherapeutics (CLDI) Assets Average (2022 - 2026)
Calidi Biotherapeutics (CLDI) posted quarterly Assets Average of $11.4 million for Q4 2025, up 9.82% year-over-year from $10.4 million in Q4 2024, and down 2.11% quarter-over-quarter from $11.7 million in Q3 2025.
Calidi Biotherapeutics (CLDI) Assets Average (2022 - 2026) Analysis & Trends
Calidi Biotherapeutics' Assets Average history runs 4 years deep, the most recent figure standing at $11.4 million for Q4 2025.
- In Q4 2025, Assets Average rose 9.82% year-over-year to $11.4 million; the TTM figure through Dec 2025 stood at $11.4 million (up 9.82% YoY), while the FY2025 annual figure was $11.5 million, down 4.8% from the prior year.
- Assets Average for Q4 2025 stood at $11.4 million, down from $11.7 million in the prior quarter.
- The five-year high for Assets Average was $231.5 million in Q1 2022, with the low at $5.7 million in Q4 2023.
- The 4-year median for Assets Average is $13.4 million (2025), against an average of $49.9 million.
- The sharpest annual moves came in 2023 and 2024: Assets Average tumbled 90.11% in 2023, then soared 84.11% in 2024.
- Calidi Biotherapeutics' Assets Average stood at $22.4 million in 2022, then tumbled by 74.71% to $5.7 million in 2023, then jumped by 84.11% to $10.4 million in 2024, then gained by 9.82% to $11.4 million in 2025.
- Business Quant data shows CLDI's Assets Average at $11.4 million in Q4 2025, $11.7 million in Q3 2025, and $12.2 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.34 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.09 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.27 Bn |
| 10 | Calidi Biotherapeutics | 1.88 Mn | -2.22 Mn | - | 8.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.03 Mn |
| Dec 31, 2025 | 11.44 Mn |
| Sep 30, 2025 | 11.69 Mn |
| Jun 30, 2025 | 12.21 Mn |
| Mar 31, 2025 | 14.62 Mn |
| Dec 31, 2024 | 10.42 Mn |
| Sep 30, 2024 | 6.54 Mn |
| Jun 30, 2024 | 6.92 Mn |
| Mar 31, 2024 | 8.71 Mn |
| Dec 31, 2023 | 5.66 Mn |
| Sep 30, 2023 | 22.65 Mn |
| Jun 30, 2023 | 43.59 Mn |
| Mar 31, 2023 | 22.89 Mn |
| Dec 31, 2022 | 22.38 Mn |
| Sep 30, 2022 | 136.59 Mn |
| Jun 30, 2022 | 231.13 Mn |
| Mar 31, 2022 | 231.50 Mn |